The Utilities of Estrogen Receptor, Cytokeratin 5/6, and Cytokeratin 903 to Differentiate Between Usual Ductal Hyperplasia, Flat Epithelial Atypia, Atypical Ductal Hyperplasia, Ductal Carcinoma In Situ, and Lobular Carcinoma In Situ

被引：0
|
作者：
Wei, Eric [1 ]
Dela Cruz, Nestor [1 ]
机构：
[1] LSU Hlth Sci Ctr, New Orleans, LA USA
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2018年 / 149卷
关键词：
D O I：
10.1093/ajcp/aqx116.067
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
68
引用
收藏
页码：S30 / S30
页数：1
相关论文
共 50 条
  • [1] Estrogen Receptor and Cytokeratin 5 Are Reliable Markers to Separate Usual Ductal Hyperplasia From Atypical Ductal Hyperplasia and Low-Grade Ductal Carcinoma In Situ
    Martinez, Anthony P.
    Cohen, Cynthia
    Hanley, Krisztina Z.
    Li, Xiaoxian
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2016, 140 (07) : 686 - 689
  • [2] Upstaging of Atypical Ductal Hyperplasia and Flat Epithelial Atypia to Ductal Carcinoma In Situ and Invasive Breast Cancer
    Lazar, M.
    Gresik, C.
    Sullivan, M.
    Helenowski, I.
    Khan, S.
    Bethke, K. P.
    Jeruss, J. S.
    Hansen, N. M.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S50 - S51
  • [3] Cytokeratin 5/6 distinguishes solid papillary ductal carcinoma in-situ from florid usual ductal hyperplasia
    Rabban, JT
    Koerner, FC
    Lerwill, MF
    MODERN PATHOLOGY, 2005, 18 : 47A - 47A
  • [4] Cytokeratin 5/6 distinguishes solid papillary ductal carcinoma in-situ from florid usual ductal hyperplasia
    Rabban, JT
    Koerner, FC
    Lerwill, MF
    LABORATORY INVESTIGATION, 2005, 85 : 47A - 47A
  • [5] Management of atypical lobular hyperplasia, atypical ductal hyperplasia, and lobular carcinoma in situ
    Clauser, Paola
    Marino, Maria A.
    Baltzer, Pascal A. T.
    Bazzocchi, Massimo
    Zuiani, Chiara
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (03) : 335 - 346
  • [6] Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6
    Rabban, Joseph T.
    Koerner, Frederick C.
    Lerwill, Melinda F.
    HUMAN PATHOLOGY, 2006, 37 (07) : 787 - 793
  • [7] Can high molecular weight cytokeratin, CK-903, differentiate benign proliferative breast lesions from atypical ductal hyperplasia and ductal carcinoma in situ?
    Aziz, M.
    Troob, S.
    Simpson, S.
    Mills, C.
    Bernik, S.
    LABORATORY INVESTIGATION, 2007, 87 : 23A - 23A
  • [8] Can high molecular weight cytokeratin, CK-903, differentiate benign proliferative breast lesions from atypical ductal hyperplasia and ductal carcinoma in situ?
    Aziz, M.
    Troob, S.
    Simpson, S.
    Mills, C.
    Bernik, S.
    MODERN PATHOLOGY, 2007, 20 : 23A - 23A
  • [9] Expression of cyclins in ductal hyperplasia, atypical ductal hyperplasia and ductal carcinoma in situ of the breast
    Kim, HJ
    Jung, WH
    Kim, DY
    Lee, HD
    YONSEI MEDICAL JOURNAL, 2000, 41 (03) : 345 - 353
  • [10] Update on atypical epithelial hyperplasia and ductal carcinoma in situ
    Simpson, Jean F.
    PATHOLOGY, 2009, 41 (01) : 36 - 39
12345